ArticleTherapeutic advances in drug safety2025

Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System.

Nunzia Balzano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.